Tadalafil Impurity A:
(6R,12aS)-6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydro pyrazino [1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione ; CAS : 171596-27-3 ; C22H19N3O4 ; MW: 389.40 ; |
Tadalafil Impurity B:
(6S,12aS)-6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydro pyrazino [1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione ; CAS : 629652-72-8 ; C22H19N3O4 ; MW: 389.40 ; |
Tadalafil Impurity C:
(6S,12aR)-6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydro pyrazino [1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione ; CAS : 171596-28-4 ; C22H19N3O4 ; MW: 389.40 ; |
Tadalafil Impurity D:
(6bR)-12-(1,3-Benzodioxol-5-yl)-12a-hydroxy-8-methyl-6a,6b,8,9,12,12a-hexahydropyrazino[1′,2′:1,2]-pyrrolo[3,4-c]quinoline-6,7,10(5H)-trione ; CAS : 951661-81-7 ; C22H19N3O6 ; MW: 421.40 ; |
Tadalafil Impurity E:
(6R,12aR,12bR)-6-(1,3-Benzodioxol-5-yl)-6a-hydroxy-2-methyl-2,3,6a,7,12a,12b-hexahydropyrazino[1′,2′:1,5]-pyrrolo[3,4-b]quinoline-1,4,12(6H)-trione ; C22H19N3O6 ; MW: 421.40 ; |
Tadalafil Impurity F:
(8a′R)-6′-(1,3-Benzodioxol-5-yl)-2′-methyl-2′,3′,8′,8a′-tetrahydro-6′H-spiro[3,1-benzoxazine-4,7′-pyrrolo[1,2a]pyrazine]-1′,2,4′(1H)-trione ; C22H19N3O6 ; Mol. Wt.: 421.4 ; |
Tadalafil Impurity G:
(12bR)-6-(1,3-Benzodioxol-5-yl)-12-hydroxy-2-methyl-2,3,6,12b-tetrahydropyrazino[1′,2′:1,5]pyrrolo[3,4-b]quinoline-1,4-dione ; CAS : 531500-48-8 (S-isomer) ;C22H17N3O5 ; Mol. Wt.: 403.39 ; |
Tadalafil Impurity H :
Tadalafil Ketolactam ; (6R,14aR)-6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,14,14a-tetrahydropyrazino[1,2-d][1,4]benzodiazonine-1,4,7,13(6H,8H)-tetrone ; CAS : 1346605-38-6 ; C22H19N3O6 ; Mol. Wt.: 421.4 ; |
Tadalafil Impurity I:
(8a′R)-6′-(1,3-Benzodioxol-5-yl)-2′-methyl-2′,3′,8′,8a′-tetrahydro-6′H-spiro[indole-3,7′-pyrrolo[1,2-a]pyrazine]-1′,2,4′(1H)-trione ; C22H19N3O5 ; Mol. Wt.: 405.4 ; |